Efgartigimod alfa Interactions
There are 304 drugs known to interact with efgartigimod alfa, along with 3 disease interactions. Of the total drug interactions, 45 are major, 250 are moderate, and 9 are minor.
- View all 304 medications that may interact with efgartigimod alfa
- View efgartigimod alfa disease interactions (3)
Most frequently checked interactions
View interaction reports for efgartigimod alfa and the medicines listed below.
- Actonel (risedronate)
- Advair Diskus (fluticasone / salmeterol)
- Afrin (oxymetazoline nasal)
- Afrin Sinus (oxymetazoline nasal)
- Ambien (zolpidem)
- Astepro (azelastine nasal)
- Ativan (lorazepam)
- Atrovent HFA (ipratropium)
- B-12 Dots (cyanocobalamin)
- B-Complex with B-12 (multivitamin)
- Bystolic (nebivolol)
- Calcium 600 D (calcium / vitamin d)
- Citracal + D (calcium / vitamin d)
- Clarinex (desloratadine)
- Clarinex-D 24 Hour (desloratadine / pseudoephedrine)
- Clinpro 5000 (fluoride topical)
- Coenzyme Q10 (ubiquinone)
- Combivent (albuterol / ipratropium)
- Cozaar (losartan)
- Daily Multi-Vitamins with Minerals (multivitamin with minerals)
- Enbrel (etanercept)
- Entocort EC (budesonide)
- EpiPen (epinephrine)
- Ethedent (fluoride topical)
- Finacea (azelaic acid topical)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flax Seed Oil (flax)
- Flovent (fluticasone)
- Inveltys (loteprednol ophthalmic)
- Journavx (suzetrigine)
Efgartigimod alfa disease interactions
There are 3 disease interactions with efgartigimod alfa which include:
Report options
QR code containing a link to this page
More about efgartigimod alfa
- efgartigimod alfa consumer information
- Compare alternatives
- Reviews (17)
- Side effects
- Dosage information
- During pregnancy
- Drug class: immune globulins
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
